Corteva AI Stock Analysis
Corteva (2X0) AI Stock Analysis
Corteva
(BX Swiss:2X0)
No summary available
Corteva (2X0) vs. iShares MSCI Switzerland ETF (EWL)
- Market Cap
- CHF 6.29B
- Dividend Yield
- 4.80%
- Average Volume (3M)
- 290
- Price to Earnings (P/E)
- 7.8
- Beta (1Y)
- 1.37
- Revenue Growth
- -5.96%
- EPS Growth
- -57.21%
- Country
- Switzerland
- Employees
- 21,500
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Agricultural Inputs
Corteva Business Overview & Revenue Model
Company Description
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait techno...
Corteva Earnings Call Summary
The call presented strong execution, innovation, productivity and growth across North America, EMEA and Asia Pacific, supported by new product growth and expanded year-to-date margins. However, the significant deterioration in Brazil, elevated channel inventory, pricing pressure, lower full-year EBITDA guidance and an expected fourth-quarter EBITDA decline were central to the discussion. The negative Brazil-driven outlook outweighed the otherwise solid performance in the rest of the business.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Corteva updated 2026 stand-alone operating EBITDA guidance to a range of $1.1 billion to $1.125 billion, with full year operating EBITDA expected to be down 12% versus last year at the midpoint and operating EBITDA margin of about 15%; fourth quarter EBITDA is expected to be about half of 2025 levels on an adjusted pro forma basis, operating EPS is expected to be in the range of $0.76 to $0.80 per share, up about 3% at the midpoint, and the full year EBITDA impact related to elevated channel inventory is estimated at approximately $100 million. Fourth quarter revenue is expected to be around $2 billion, down year-over-year, with volumes generally flat year-over-year and pricing down high single digits; U.S. acetochlor is expected to contribute a fourth-quarter headwind closer to that $40-ish million level, with a little bit of it in the first quarter and no year-over-year headwinds expected by the second quarter of 2027. Corteva remains on track for a year-end cash position of about $1.5 billion, around $1 billion of financial debt, underlying fourth-quarter CapEx of about $50 million, and expects to grow the business in 2027.
Corteva Risk Analysis
Corteva disclosed 31 risk factors in its most recent earnings report. Corteva reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
0 New RisksCorteva Peers Comparison
Overall Rating
CF77Outperform
ICL55Neutral
MOS47Neutral
FMC42Neutral
BIOX38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | $18.30B | 8.80 | 40.30% | 1.76% | 17.87% | 70.91% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 55Neutral | $5.83B | 18.64 | 5.09% | 4.56% | 10.15% | -15.98% | |
| 47Neutral | $6.97B | -16.48 | -3.78% | 4.01% | 0.02% | -191.20% | |
| 42Neutral | $810.46M | -0.16 | -308.88% | 6.14% | -21.99% | -677.23% | |
| 38Underperform | $13.40M | -0.06 | -216.09% | ― | -26.10% | 14.85% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CH:2X0 | Corteva | 11.95 | 1.24 | 11.58% | |
| CF | Cf Industries Holdings, Inc. | 125.09 | 45.56 | 57.30% | |
| FMC | FMC Corp | 5.21 | -7.40 | -58.69% | |
| MOS | Mosaic Co | 21.92 | -1.73 | -7.32% | |
| ICL | Icl Group Ltd. | 4.52 | -0.70 | -13.39% | |
| BIOX | Bioceres Crop Solutions | 0.21 | -1.33 | -86.41% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
